Market Closed

NIKI
Niki BioSolutions, Inc. Common Stock
$ 1.65
-2.94%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 21 hours ago

Niki BioSolutions, Inc. Common Stock News

Latest Niki BioSolutions, Inc. Common Stock Stock News & NIKI Headlines

Niki BioSolutions Announces Presentation at the Clinical Trials on Alzheimer's Disease (CTAD) 2026 Conference
5 days ago | globenewswire.com
Niki BioSolutions Announces New York State Approval for Its APOE Genotyping Test Using Dried Blood Spots, Plasma, and Urine
19 days ago | globenewswire.com
Niki BioSolutions Signs Agreement to Supply APOE Genotyping to Charter Research
22 days ago | globenewswire.com
Niki BioSolutions' Rett Syndrome Biomarker Program Featured in the International Rett Syndrome Foundation's “Rett Research Tool Belt” Series
a month ago | globenewswire.com
Niki BioSolutions Accelerates Its Alzheimer's Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics
2 months ago | globenewswire.com
Aptorum Group Provides Update on DiamiR Biosciences Merger
4 months ago | globenewswire.com
Aptorum Group Provides Update on DiamiR Biosciences Merger
4 months ago | globenewswire.com
Aptorum Group and DiamiR Biosciences Announce Three Presentations at 2026 Alzheimer's Association International Conference
4 months ago | globenewswire.com
Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer's Disease Biomarkers
5 months ago | globenewswire.com
Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences
5 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

NIKI
Niki BioSolutions, Inc. Common Stock
$ 1.65
-2.94%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 21 hours ago